NSE: GPTHEALTH · Hospital
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
GPT Healthcare Limited operates a chain of multispecialty hospitals under the ILS Hospitals brand, providing a wide range of medical services including surgery, critical care, and diagnostics. The company also manages integrated pharmacy operations to support its clinical services.
The company generates revenue through the provision of comprehensive healthcare services across various medical specialties and the operation of in-house pharmacies. It functions as a multispecialty hospital chain primarily serving patients in Eastern India.
Growth is driven by the expansion of multispecialty healthcare services and the scaling of its hospital network under the ILS Hospitals brand. The company continues to focus on enhancing its diagnostic and surgical capabilities to capture increasing demand for private healthcare.
Unlock AI insights, financials, peers and live data on Gpt Healthcare Ltd. and 5,000+ companies — free.
REVENUE
₹473 Cr
TTM · standalone
NET PROFIT
₹42 Cr
TTM · standalone
EPS
₹5.15
TTM · standalone
RETURN ON EQUITY
16.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
19.2%
TTM · standalone
P/E
29.9x
Q4 FY26 · standalone
EV/EBITDA
14.1x
Q4 FY26 · standalone
EBITDA MARGIN
19.1%
TTM · standalone
NET PROFIT MARGIN
11.5%
Q4 FY26 · standalone
DEBT TO EQUITY
0.1x
Q4 FY26 · standalone
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Gpt Healthcare Ltd.GPTHEALTH | 980 | 29.86 | 14.13 | 16.1% | 19.1% | 16.7% | 19.2% | -12.4% |
Artemis Medicare Services Ltd.ARTEMISMED | 3,537 | 41.98 | 20.84 | 15.4% | 20.2% | 12.0% | 14.4% | +9.9% |
Shalby Ltd.SHALBY | 1,466 | 51.54 | 13.59 | 5.0% | 14.9% | 3.5% | 8.0% | -16.4% |
Gujarat KidneyGKSL | 812 | — | — | — | 33.0% | — | — | — |
Lotus Eye Hospital And Institute Ltd.LOTUSEYE | 219 | 3064.25 | 58.01 | 8.4% | 8.5% | 0.1% | 1.2% | +59.7% |
Hannah JosephHANNAH | 138 | — | — | — | 27.0% | — | — | — |
As of Q4 FY26
Gpt Healthcare Ltd.
NSE: GPTHEALTH · Hospital
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
GPT Healthcare Limited operates a chain of multispecialty hospitals under the ILS Hospitals brand, providing a wide range of medical services including surgery, critical care, and diagnostics. The company also manages integrated pharmacy operations to support its clinical services.
The company generates revenue through the provision of comprehensive healthcare services across various medical specialties and the operation of in-house pharmacies. It functions as a multispecialty hospital chain primarily serving patients in Eastern India.
Growth is driven by the expansion of multispecialty healthcare services and the scaling of its hospital network under the ILS Hospitals brand. The company continues to focus on enhancing its diagnostic and surgical capabilities to capture increasing demand for private healthcare.
Loading…
Unlock AI insights, financials, peers and live data on Gpt Healthcare Ltd. and 5,000+ companies — free.
REVENUE
₹473 Cr
TTM · standalone
NET PROFIT
₹42 Cr
TTM · standalone
EPS
₹5.15
TTM · standalone
RETURN ON EQUITY
16.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
19.2%
TTM · standalone
P/E
29.9x
Q4 FY26 · standalone
EV/EBITDA
14.1x
Q4 FY26 · standalone
EBITDA MARGIN
19.1%
TTM · standalone
NET PROFIT MARGIN
11.5%
Q4 FY26 · standalone
DEBT TO EQUITY
0.1x
Q4 FY26 · standalone
As of Q4 FY26